Gilarevsky S.R. Clinical Efficacy and Mechanisms of Actions of the Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and High Risk of Cardiovascular Diseases. Kardiologiia. 2021;61(4):66-72. (In Russ.) https://doi.org/10.18087/cardio.2021.4.n1549
Email this article (Login required)
Email the author (Login required) 
Post a Comment (Login required)
office 215, 5, Beregovoy proezd, Moscow, 121087
Publisher: Regional public organization for popularization of scientific and medical literature "Cardiomag". OGRN 1067799014436
tel.: (495) 211–6994
e-mail: info.cardiomag@gmail.com
